253 followers
Perhaps perceived as "gross" by IBD patients, these topical products can have good efficacy and a good safety profile. It's too bad pharma doesn't seem to be innovating newer products and formulations. https://t.co/hlfXgUa7wb
Perhaps perceived as "gross" by IBD patients, these topical products can have good efficacy and a good safety profile. It's too bad pharma doesn't seem to be innovating newer products and formulations. https://t.co/hlfXgUa7wb
New NNT→Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance,… https://t.co/nNEX1TseUI